Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | -1.35% | +1.05% | +8.08% |
14/05 | Eterna Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/05 | Eterna Therapeutics Inc. Appoints Mahendra Rao to Its Scientific Advisory Board | CI |
Sales 2022 | - | Sales 2023 | 0.07 5.68 | Capitalization | 9.71M 811M |
---|---|---|---|---|---|
Net income 2022 | -24M -2B | Net income 2023 | -21M -1.75B | EV / Sales 2022 | - |
Net cash position 2022 | 10.26M 857M | Net Debt 2023 | 34.27M 2.86B | EV / Sales 2023 | 64,67,58,000 x |
P/E ratio 2022 |
-0.4
x | P/E ratio 2023 |
-0.44
x | Employees | 8 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.69% |
1 day | -1.35% | ||
1 week | +1.05% | ||
Current month | +2.11% | ||
1 month | -2.51% | ||
3 months | -18.49% | ||
6 months | +3.74% | ||
Current year | +8.08% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjeev Luther
CEO | Chief Executive Officer | 62 | 01/01 |
Sandra Gurrola
DFI | Director of Finance/CFO | 57 | 21/21/21 |
Megan Yung
LAW | General Counsel | - | 24/23/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Bristol
CHM | Chairman | 77 | 30/23/30 |
William Wexler
BRD | Director/Board Member | 65 | 07/22/07 |
Dorothy Clarke
BRD | Director/Board Member | 59 | 28/23/28 |
Date | Price | Change | Volume |
---|---|---|---|
21/24/21 | 1.94 | -1.35% | 3,885 |
20/24/20 | 1.966 | +1.19% | 6,322 |
18/24/18 | 1.943 | -1.36% | 4,423 |
17/24/17 | 1.97 | +2.61% | 1,885 |
Delayed Quote Nasdaq, June 22, 2024 at 01:30 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+8.08% | 10.5M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+36.33% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- ERNA Stock